Daytime Station Support Program
Membership Campaign Program
Summer of Service Program
Few tech consumers think of their devices in terms of product design. But we immediately (if subconsciously) recognize quality when we experience it: a website that quickly delivers relevant services or search results, or a mobile app that intuitively responds to your touch, swipe or pinch. Touchscreens and gesture-recognition are rapidly changing the way we interact with technology. Tech Tuesday considers how those new interfaces are changing user experience.
The way we interact with technology is changing rapidly. We control smartphones and tablet computers with pinches, zooms and swipes on touchscreens. New game systems like the Microsoft Kinect and Nintendo Wii respond to user gestures and movements. The Siri personal assistant program on new iPhones responds to voice commands and questions. Google has even recently announced a plan for "augmented reality" glasses.
These new devices and controls could lead to better, more intuitive technology - or they could lead to frustrating and confusing experiences. This Tech Tuesday, we explore the multidisciplinary field of "User Experience" (UX).
Guest Greg Flory flags two examples of interesting apps, designed on the Apple iOS system (you can check out Apple's iOS "Human Interface Guidelines" here):
Clear App for iPhone:
Rechner Calculator for iPhone:
Many of these new products are designed primarily for entertainment or personal organization. But they could have significant impacts across the technology field in the coming decades. Reed flags InterKnowlogy, a software company that designed gesture recognition application for the health sector:
Many leading practitioners in the UX field will be attending the MoDevUX conference in Tysons Corner on April 20th, 2012. Details here.
Earlier this month, the House of Representatives passed the 21st Century Cures Act in a rare bi-partisan effort. The bill is meant to speed the development of lifesaving treatments, but critics warn it may also allow ineffective or even harmful drugs onto the market.